These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 19802805
1. [PTH measurement: where do we stand?]. Marangella M. G Ital Nefrol; 2009; 26(5):600-7. PubMed ID: 19802805 [Abstract] [Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. [Intact whole bioactive parathormone: problems arising from comparing different methods]. Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D. G Ital Nefrol; 2002 Nov; 19(4):467-75. PubMed ID: 12369051 [Abstract] [Full Text] [Related]
4. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B. Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888 [Abstract] [Full Text] [Related]
5. Immunoassays for the detection of parathyroid hormone. Jüppner H, Potts JT. J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782 [Abstract] [Full Text] [Related]
12. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients. Chudek J, Piecha G, Kokot F, Wiecek A. J Nephrol; 2003 Sep; 16(5):710-5. PubMed ID: 14733418 [Abstract] [Full Text] [Related]
13. Race and sex: predictors of the severity of hyperparathyroidism in peritoneal dialysis patients. Fan SL, Chan A, Raftery MJ, Yaqoob MM. Nephrology (Carlton); 2006 Feb; 11(1):15-20. PubMed ID: 16509926 [Abstract] [Full Text] [Related]
15. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Almond A, Ellis AR, Walker SW, Scottish Clinical Biochemistry Managed Diagnostic Network. Ann Clin Biochem; 2012 Jan; 49(Pt 1):63-7. PubMed ID: 22096021 [Abstract] [Full Text] [Related]
16. Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure. Worth GK, Vasikaran SD, Retallack RW, Musk AA, Gutteridge DH. Ann Clin Biochem; 2004 Mar; 41(Pt 2):149-54. PubMed ID: 15025807 [Abstract] [Full Text] [Related]
17. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788 [Abstract] [Full Text] [Related]
18. A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B. Surgery; 2007 Sep; 142(3):398-404. PubMed ID: 17723893 [Abstract] [Full Text] [Related]
20. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy. Kato Y, Yamaguchi S, Yachiku S, Fujisawa M, Kawakami N. Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]